Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings Current Ratio 2010-2025 | CPHI

China Pharma Holdings current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
China Pharma Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.00B $0.01B 0.56
2024-12-31 $0.00B $0.01B 0.65
2024-09-30 $0.00B $0.01B 0.79
2024-06-30 $0.00B $0.01B 0.84
2024-03-31 $0.01B $0.01B 0.90
2023-12-31 $0.01B $0.01B 0.88
2023-09-30 $0.01B $0.01B 0.82
2023-06-30 $0.01B $0.01B 0.52
2023-03-31 $0.01B $0.01B 0.51
2022-12-31 $0.01B $0.01B 0.47
2022-09-30 $0.01B $0.01B 0.44
2022-06-30 $0.01B $0.01B 0.75
2022-03-31 $0.01B $0.01B 0.83
2021-12-31 $0.01B $0.01B 0.87
2021-09-30 $0.00B $0.01B 0.40
2021-06-30 $0.01B $0.01B 0.43
2021-03-31 $0.01B $0.01B 0.44
2020-12-31 $0.01B $0.01B 0.47
2020-09-30 $0.01B $0.01B 0.44
2020-06-30 $0.01B $0.01B 0.64
2020-03-31 $0.01B $0.01B 0.57
2019-12-31 $0.01B $0.01B 0.56
2019-09-30 $0.01B $0.01B 0.65
2019-06-30 $0.01B $0.01B 0.86
2019-03-31 $0.01B $0.01B 0.89
2018-12-31 $0.01B $0.01B 0.87
2018-09-30 $0.01B $0.01B 0.99
2018-06-30 $0.01B $0.01B 1.35
2018-03-31 $0.01B $0.01B 1.40
2017-12-31 $0.01B $0.01B 1.33
2017-09-30 $0.02B $0.01B 1.44
2017-06-30 $0.02B $0.01B 1.64
2017-03-31 $0.02B $0.01B 1.66
2016-12-31 $0.02B $0.01B 1.69
2016-09-30 $0.02B $0.01B 1.62
2016-06-30 $0.02B $0.01B 1.69
2016-03-31 $0.03B $0.01B 1.79
2015-12-31 $0.02B $0.01B 1.90
2015-09-30 $0.04B $0.02B 2.24
2015-06-30 $0.04B $0.01B 3.07
2015-03-31 $0.04B $0.02B 2.79
2014-12-31 $0.04B $0.01B 2.96
2014-09-30 $0.06B $0.01B 4.46
2014-06-30 $0.07B $0.01B 5.81
2014-03-31 $0.08B $0.01B 6.64
2013-12-31 $0.08B $0.01B 6.99
2013-09-30 $0.10B $0.01B 7.59
2013-06-30 $0.10B $0.02B 6.97
2013-03-31 $0.11B $0.01B 8.57
2012-12-31 $0.11B $0.02B 7.69
2012-09-30 $0.12B $0.02B 7.18
2012-06-30 $0.12B $0.02B 7.13
2012-03-31 $0.12B $0.02B 6.78
2011-12-31 $0.11B $0.01B 8.03
2011-09-30 $0.11B $0.01B 8.04
2011-06-30 $0.10B $0.01B 8.19
2011-03-31 $0.10B $0.01B 7.62
2010-12-31 $0.09B $0.01B 7.18
2010-09-30 $0.09B $0.01B 7.73
2010-06-30 $0.08B $0.01B 6.47
2010-03-31 $0.08B $0.01B 7.06
2009-12-31 $0.07B $0.01B 6.79
2009-09-30 $0.07B $0.01B 6.93
2009-06-30 $0.06B $0.01B 8.08
2009-03-31 $0.06B $0.01B 9.32
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.006B $0.005B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.223B 6.87
Dr Reddy's Laboratories (RDY) India $12.581B 22.83
BridgeBio Pharma (BBIO) United States $8.518B 0.00
Bausch Health Cos (BHC) Canada $2.391B 1.72
Supernus Pharmaceuticals (SUPN) United States $1.745B 14.16
Amphastar Pharmaceuticals (AMPH) United States $1.088B 7.30
Personalis (PSNL) United States $0.581B 0.00
Taysha Gene Therapies (TSHA) United States $0.511B 0.00
Assembly Biosciences (ASMB) United States $0.132B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00